Abstract
The present invention relates to a method for predicting the risk of developing Insulin resistance and/or type 2 diabetes and/or metabolic syndrome for a subject, based on the levels of DLK1. A determined level above a reference level is indicative of said subject being at risk of developing Insulin resistance and/or type 2 diabetes and/or metabolic syndrome and a determined level equal to or below the reference level is indicative of said subject not being currently at risk of developing Insulin resistance and/or type 2 diabetes and/or metabolic syndrome.
| Originalsprog | Engelsk |
|---|---|
| IPC | C12Q 1/ 6883 A I |
| Patentnummer | EP3657176 |
| Land/Område | Danmark |
| Prioritetsdato | 23/11/2018 |
| Prioritetsnummer | EP20180207954 |
| Status | Udgivet - 27. maj 2020 |